首页> 外文期刊>EFSA Journal >Re‐evaluation of acacia gum (E?414) as a food additive
【24h】

Re‐evaluation of acacia gum (E?414) as a food additive

机译:重新评估相思树胶(E?414)作为食品添加剂

获取原文
       

摘要

The Panel on Food Additives and Nutrient Sources added to Food (ANS) provides a scientific opinion re‐evaluating the safety of acacia gum (E 414) as a food additive. In the EU, acacia gum has not been formally evaluated by the Scientific Committee for Food (SCF), and therefore, no ADI has been allocated. However, it was accepted for use in weaning food (SCF, 1991). In 1999, the SCF considered ‘that the use of acacia gum/gum arabic in coatings for nutrient preparations containing trace elements is acceptable provided carry‐over levels in infant formulae, follow‐on formulae or FSMP do not exceed 10 mg/kg’. Acacia gum was evaluated by JECFA in 1982 and 1990 and the specifications were amended in 1998. Based on the lack of adverse effects in the available toxicity studies, an ADI ‘not specified’ was allocated. Following the conceptual framework for the risk assessment of certain food additives re‐evaluated under Commission Regulation (EU) No 257/2010, the Panel considered that adequate exposure and toxicity data were available. Acacia gum is unlikely to be absorbed intact and is slightly fermented by intestinal microbiota. No adverse effects were reported in subchronic and carcinogenicity studies at the highest dose tested and there is no concern with respect to the genotoxicity. Oral daily intake of a large amount of acacia gum up to 30,000 mg acacia gum/person per day (approximately equivalent 430 mg acacia gum/kg bw per day) for up to 18 days was well tolerated in adults but some individuals experienced flatulence which was considered by the Panel as undesirable but not adverse effect. The Panel concluded that there is no need for a numerical ADI for acacia gum (E 414), and there is no safety concern for the general population at the refined exposure assessment of acacia gum (E 414) as a food additive.
机译:食品中添加的食品添加剂和营养来源专家组(ANS)提供了科学意见,重新评估了阿拉伯胶(E 414)作为食品添加剂的安全性。在欧盟,食品科学委员会(SCF)尚未对阿拉伯胶进行正式评估,因此未分配ADI。但是,它被认可用于断奶食品(SCF,1991)。 1999年,SCF认为“如果婴儿配方食品,后续配方食品或FSMP中的残留量不超过10 mg / kg,则在含有微量元素的营养制剂的包衣中使用阿拉伯胶/阿拉伯树胶是可以接受的”。 JECFA在1982年和1990年对相思树胶进行了评估,并于1998年对规格进行了修订。基于现有毒性研究中没有不良影响的依据,ADI被指定为“未指定”。根据委员会法规(EU)257/2010号重新评估某些食品添加剂的风险评估的概念框架后,专家组认为可获得足够的暴露和毒性数据。相思树胶不太可能被完整吸收,并且会被肠道菌群稍微发酵。在亚慢性和致癌性研究中,以最高测试剂量未见不良反应,也没有涉及遗传毒性。在成年人中,口服耐受的每日摄入量高达30,000毫克相思树胶/人每天(相当于每天430毫克相思树胶/ kg bw)大约是成年人的耐受性,但有些人会出现肠胃胀气小组认为这是不利的,但不是不利的影响。专家小组得出结论,对阿拉伯胶(E 414)不需要数字ADI,在对阿拉伯胶作为食品添加剂的精细暴露评估(E 414)中,普通人群也没有安全方面的担忧。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号